Telemonitoring Can Make Cardiac Implant Therapy More Efficient and Cost-Effective

The possibility to monitor patients and their cardiac implants such as pacemakers or defibrillators remotely has the potential to improve the efficiency of Cardiac Implant Electronic Device (CIED) therapy, and make the treatment more cost-effective. Nonetheless, to date, remote monitoring of patients is still not used widely throughout Europe. Findings from the research "Moving towards good practice in the reimbursement of CIED Telemonitoring", which was published today by PwC in cooperation with Eucomed and EHRA, the European Heart Rhythm Association, concluded that appropriate reimbursement systems are critical in fostering uptake of such innovative telemonitoring solutions.

The research was conducted in five EU countries - Germany, Italy, Spain, The Netherlands and the UK - and found that more widespread use of CIED remote follow-ups and monitoring can be fostered by putting in place appropriate policies, guidelines and reimbursement mechanisms enabling the technology to support some key objectives of healthcare systems: better access to care, efficiency, cost-effectiveness, and high-quality clinical outcomes and patient experiences.

The three key stakeholders at European level, industry, healthcare providers and the patient, must step up, the paper notes:

  • Industry has to come up with solutions which limit the investment hurdle for setting up the appropriate infrastructure, such as connectivity options
  • Healthcare providers should advocate the benefits, in terms of clinical outcome, cost-effectiveness and quality of life, of remote follow-up
  • Patients need to demonstrate willingness to let go of the old idea of face-to-face follow-up and be willing to replace it with remote follow-up where appropriate

Recommendations for payers are more country-specific. One such payer, the UK Department of Health, is invited to develop a programme of clinician training and engagement. The aim of the programme is to foster a greater understanding of the benefits of remote follow-ups but also to increase acceptance of remote monitoring solutions. The report includes country-specific recommendations for all five countries.

Dr Martin Schloh, Partner at PwC said: "With ever more budgetary pressure being put on healthcare systems, remote monitoring technology can help in keeping healthcare provision sustainable today, tomorrow and in the coming years. What the research clearly shows is that the potential is there, but countries need to overcome the hurdles outlined in the white paper before we can fully realise the benefits of remote monitoring solutions."

With reimbursement being a national issue, the recommendations in the White Paper are necessarily country-specific. "Recommendations are tailored to each country and based on a thorough analysis of the situation and the ongoing health policy activities around E-Health and Telemonitoring in each of the five countries," Markus Siebert, Chair of the Eucomed Cardiac Rhythm Management (CRM) Telemonitoring group commented on the recommendations of the paper. "As there is no “one size fits all” solution in reimbursement, it was key to suggest realistic recommendations which would be actionable at national level and which would inspire the national debate and policy making," he concluded.

In view of these prerequisites, the European Heart Rhythm Association (EHRA), national working groups on arrhythmia and pacing, Eucomed and PwC are meeting today at the European Society of Cardiology (ESC) congress to discuss how to put the white paper recommendations into practice as a stepping stone towards fair, transparent and sustainable reimbursement systems.

"In those hospitals where remote monitoring is already an option today, patients, nurses and physicians are highly satisfied with its benefits. Nonetheless, its "real world" implementation would see enormous growth if appropriate reimbursement systems for the medical activity, the technology and the healthcare service would be in place; until then, telemonitoring will always be in a disadvantaged position," Dr Angelo Auricchio, President of EHRA, said, adding that "as EHRA we are pleased to be part of this important project of applied health policy research and hope that the recommendations in the White Paper will further support implementation of telemonitoring across Europe, to the benefit of patients, healthcare systems and society at large."

About Eucomed
Eucomed is the European medical technology industry association. Its mission is to make modern, innovative and reliable medical technology available to more people. Eucomed represents directly and indirectly 22,500 designers, manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and amelioration of disease and disability. Small and medium sized companies make up more than 80% of this sector. The European medical technology industry generates annual sales of €95 billion, invests some €7.5 billion in R&D and employs around 500,000 highly skilled workers. For more information visit www.eucomed.org.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...